Macrovascular and microvascular cerebral blood flow in adults at risk for Alzheimer's disease

Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring

Volumn 7, Issue , 2017, Pages 48-55

  Clark, Lindsay R ^a,b   Berman, Sara E ^a   Rivera Rivera, Leonardo A ^a   Hoscheidt, Siobhan M ^a   Darst, Burcu F ^a   Engelman, Corinne D ^a   Rowley, Howard A ^a   Carlsson, Cynthia M ^a,b   Asthana, Sanjay ^a,b   Turski, Patrick ^a   Wieben, Oliver ^a   Johnson, Sterling C ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

Author keywords

Alzheimer's disease; Arterial spin labeling; Cerebral blood flow; Cerebrovascular disease; Phase contrast MRI; Vascular imaging

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN BLOOD FLOW; BRAIN CAPILLARY; BRAIN MICROCIRCULATION; BRAIN PERFUSION; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HUMAN; INTERNAL CAROTID ARTERY; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY;

EID: 85013156478     PISSN: None     EISSN: 23528729     Source Type: Journal    
DOI: 10.1016/j.dadm.2017.01.002     Document Type: Article

References (27)

1. [1] Wolk, D.A., Detre, J.A., Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Curr Opin Neurol 25 (2012), 421–428.
2. [2] Zlokovic, B.V., Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12 (2011), 723–738.
3. [3] Shaw, T.G., Mortel, K.F., Meyer, J.S., Rogers, R.L., Hardenberg, J., Cutaia, M.M., Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 34 (1984), 855–862.
4. [4] Kim, S.M., Kim, M.J., Rhee, H.Y., Ryu, C.W., Kim, E.J., Petersen, E.T., et al. Regional cerebral perfusion in patients with Alzheimer's disease and mild cognitive impairment: effect of APOE epsilon4 allele. Neuroradiology 55 (2013), 25–34.
5. [5] Okonkwo, O.C., Xu, G., Oh, J.M., Dowling, N.M., Carlsson, C.M., Gallagher, C.L., et al. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cereb Cortex 24 (2014), 978–988.
6. [6] Wierenga, C.E., Clark, L.R., Dev, S.I., Shin, D.D., Jurick, S.M., Rissman, R.A., et al. Interaction of age and APOE genotype on cerebral blood flow at rest. J Alzheimers Dis 34 (2013), 921–935.
7. [7] Musiek, E.S., Chen, Y., Korczykowski, M., Saboury, B., Martinez, P.M., Reddin, J.S., et al. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimers Dement 8 (2012), 51–59.
8. [8] Alexander, G.E., Chen, K., Pietrini, P., Rapoport, S.I., Reiman, E.M., Longitudinal PET evaluation of cerebral metabolic decline in dementia: a potential outcome measure in Alzheimer's disease treatment studies. Am J Psychiatry 159 (2002), 738–745.
9. [9] Reiman, E.M., Caselli, R.J., Yun, L.S., Chen, K., Bandy, D., Minoshima, S., et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med 334 (1996), 752–758.
10. [10] Xu, G., Rowley, H.A., Wu, G., Alsop, D.C., Shankaranarayanan, A., Dowling, M., et al. Reliability and precision of pseudo-continuous arterial spin labeling perfusion MRI on 3.0 T and comparison with 15O-water PET in elderly subjects at risk for Alzheimer's disease. NMR Biomed 23 (2010), 286–293.
11. [11] Turski, P., Scarano, A., Hartman, E., Clark, Z., Schubert, T., Rivera, L., et al. Neurovascular 4DFlow MRI (phase contrast MRA): emerging clinical applications. Neurovascular Imaging 2 (2016), 1–11.
12. [12] Gu, T., Korosec, F.R., Block, W.F., Fain, S.B., Turk, Q., Lum, D., et al. PC VIPR: a high-speed 3D phase-contrast method for flow quantification and high-resolution angiography. AJNR Am J Neuroradiol 26 (2005), 743–749.
13. [13] Johnson, K.M., Lum, D.P., Turski, P.A., Block, W.F., Mistretta, C.A., Wieben, O., Improved 3D phase contrast MRI with off-resonance corrected dual echo VIPR. Magn Reson Med 60 (2008), 1329–1336.
14. [14] Rivera-Rivera, L.A., Turski, P., Johnson, K.M., Hoffman, C., Berman, S.E., Kilgas, P., et al. 4D flow MRI for intracranial hemodynamics assessment in Alzheimer's disease. J Cereb Blood Flow Metab 36 (2016), 1718–1730.
15. [15] Berman, S.E., Rivera-Rivera, L.A., Clark, L.R., Racine, A.M., Keevil, J.G., Bratzke, L.C., et al. Intracranial arterial four-dimensional flow is associated with metrics of brain health and Alzheimer's disease. Alzheimers Dement (Amst) 1 (2015), 420–428.
16. [16] Hoscheidt, S.M., Kellawan, J.M., Berman, S.E., Rivera-Rivera, L.A., Krause, R.A., Oh, J.M., et al. Insulin resistance is associated with lower arterial blood flow and reduced cortical perfusion in cognitively asymptomatic middle-aged adults. J Cereb Blood Flow Metab, 2016.
17. [17] Goff, D.C. Jr., Lloyd-Jones, D.M., Bennett, G., Coady, S., D'Agostino, R.B., Gibbons, R., et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 129 (2014), S49–S73.
18. [18] Darst, B.F., Koscik, R.L., Racine, A.M., Oh, J.M., Krause, R.A., Carlsson, C.M., et al. Pathway-specific polygenic risk scores as predictors of amyloid-beta deposition and cognitive function in a sample at increased risk for Alzheimer's disease. J Alzheimers Dis 55 (2017), 473–484.
19. [19] AlzGene. Available at: alzgene.org. Accessed July 15, 2015.
20. [20] Birdsill, A.C., Carlsson, C.M., Willette, A.A., Okonkwo, O.C., Johnson, S.C., Xu, G., et al. Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring) 21 (2013), 1313–1320.
21. [21] Gommer, E.D., Martens, E.G., Aalten, P., Shijaku, E., Verhey, F.R., Mess, W.H., et al. Dynamic cerebral autoregulation in subjects with Alzheimer's disease, mild cognitive impairment, and controls: evidence for increased peripheral vascular resistance with possible predictive value. J Alzheimers Dis 30 (2012), 805–813.
22. [22] Nation, D.A., Wierenga, C.E., Clark, L.R., Dev, S.I., Stricker, N.H., Jak, A.J., et al. Cortical and subcortical cerebrovascular resistance index in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis 36 (2013), 689–698.
23. [23] Roher, A.E., Tyas, S.L., Maarouf, C.L., Daugs, I.D., Kokjohn, T.A., Emmerling, M.R., et al. Intracranial atherosclerosis as a contributing factor to Alzheimer's disease dementia. Alzheimers Dement 7 (2011), 436–444.
24. [24] Østergaard, L., Aamand, R., Gutiérrez-Jiménez, E., Ho, Y.C., Blicher, J.U., Madsen, S.M., et al. The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging 34 (2013), 1018–1031.
25. [25] Montagne, A., Barnes, S.R., Sweeney, M.D., Halliday, M.R., Sagare, A.P., Zhao, Z., et al. Blood-brain barrier breakdown in the aging human hippocampus. Neuron 85 (2015), 296–302.
26. [26] Iturria-Medina, Y., Sotero, R.C., Toussaint, P.J., Mateos-Perez, J.M., Evans, A.C., Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis. Nat Commun, 7, 2016, 11934.
27. [27] Meng, X.F., Yu, J.T., Wang, H.F., Tan, M.S., Wang, C., Tan, C.C., et al. Midlife vascular risk factors and the risk of Alzheimer's disease: a systematic review and meta-analysis. J Alzheimers Dis 42 (2014), 1295–1310.